What's coming to Contemporary OB/GYN this week?
The rate of unintended pregnancies throughout the US military declined significantly since 2005, according to a study published in Contraception.1 Nevertheless, authors say, the burden that such pregnancies place on female servicemembers and the military health care system continues to demand aggressive upfront education and counseling.
After the Antenatal Late Preterm Steroid (ALPS) trial showed a decrease in respiratory complications following steroid administration, steroid exposure among newborns increased.
While access to prenatal care did increase in states after Medicaid expansion, disparities persisted and even increased among Asian and Hispanic immigrant pregnant women, according to an analysis in JAMA Network Open.
Low-molecular-weight heparin (LMWH) did not increase the live-birth rate in comparison to standard therapy for pregnant women.
Research suggests that combined hormonal contraceptives (CHC) have a similar safety profile to progestin-only contraceptives (POC) with regard to women with sickle cell disease and their risk of thromboembolism (TE).
Adaptability and flexibility will be needed to deal with for challenges next year.
This month, the US Centers for Medicare & Medicaid Services (CMS) announced the draft rule with five key provisions and five requests for information. If implement, CMS estimated the changes would save physicians and hospitals more than $15 billion over 10 years.
Check back soon for additional updates!
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More